- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03875885
CONNECTing Head and Neck Caregivers to Supportive Care Resources (CONNECT-HNC)
April 4, 2023 updated by: Wake Forest University Health Sciences
CONNECTing Caregivers to Supportive Services (CONNECT): A Technology-Based Intervention to Connect Cancer Caregivers With Supportive Care Resources
The purpose of this research is to determine feasibility and acceptability of randomized pilot trial to evaluate a technology-based intervention (CONNECT) to empower and educate caregivers about the benefits of supportive care resources, identify their unmet needs, and connect them with resources.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The registration is for Objective two and three that refers to the clinical trial.
The investigators will determine their ability to recruit caregivers of patients with head and neck cancer being treated at Wake Forest Baptist Comprehensive Cancer Center to a study that uses a technology-based intervention, CONNECT, which may increase head and neck cancer caregivers' knowledge about the benefits of supportive care resources, identify their unmet needs, and connect them with supportive care resources.
In this study the investigators also want to look at their ability to recruit a control group of caregivers, that is, caregivers of patients with head and neck cancer being treated at Wake Forest Baptist Comprehensive Cancer Center that will receive a list of supportive care resources.
Control groups are used in research to see if the intervention being studied really does have an effect.
In addition, the investigators will determine whether or not the intervention has led to improvements in caregivers' use of supportive care resources, quality of care, and overall quality of life.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Comprehensive Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Eligible caregivers include those who are:
- Caregivers must be providing some capacity of informal (unpaid) care for a patient meeting patient eligibility criteria. If a patient unexpectedly becomes deceased during the study period, caregivers will be allowed to continue participation in the assigned study arm and complete study assessments if they wish to.
- Greater than or equal to 18 years of age.
- Ability to access study materials by internet or complete study activities in person as institutional and government policies allow.
Eligible patients include those who:
- Have new or recurrent American Joint Committee on Cancer (AJCC) stage I-IV head and neck cancer.
- Are receiving cancer treatment or awaiting planned treatment initiation, excluding those receiving neoadjuvant surgery or surgery only.
- Patients must be ambulatory and up more than 50% of waking hours, as measured by an ECOG Performance Status rating of level 0, 1, or 2.
- Greater than or equal to 18 years of age.
- Ability to access study materials by internet or complete study activities in person as institutional and government policies allow.
- Patients must be receiving some capacity of informal care from a caregiver meeting the above criteria. If the caregiver unexpectedly becomes deceased during the study period, the patient will be un-enrolled from this study as we are evaluating a caregiver-only delivered intervention.
Exclusion Criteria:
Caregivers will be excluded if:
• Cannot read/communicate in English
Patients will be excluded if they:
• Cannot read/communicate in English
Eligibility to participate in the study is conditional on participation of both the caregiver and patient.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: CONNECT Intervention Group - Group A
A web-based intervention (CONNECT) to empower and connect caregivers of newly diagnosed cancer patients to supportive care resources A randomized pilot study will be conducted to assess feasibility and acceptability and obtain data on caregiver and patient outcomes.
CONNECT e-tool, re-education and optional referral (2 weeks post CONNECT e-tool).
Baseline, one month post randomization data collection, three months post randomization data collection, quantitative and qualitative measures.
|
A novel web-based intervention with input from an advisory panel of cancer caregivers, oncology providers, and psychosocial oncology professionals empowering caregivers with needs to seek services by providing education about the benefits of supportive care resources, systematically identifying their unmet needs, and connecting them with tailored supportive care resources.
|
Other: CONNECT Comparison Group - Group B
Baseline, one month post randomization data collection, three months post randomization data collection, quantitative and qualitative measures.
|
This group will receive a generic resource list.
The generic resource list will be printed for participants and emailed to them, if participants have an email address.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Retention of Participants
Time Frame: 9 months
|
Number of participants who completed the T2 assessment divided by the number who agreed to participate
|
9 months
|
Proportion of Caregivers Who Agree to Participate
Time Frame: 19 months
|
Number of caregivers who agreed to participate divided by the number of months of recruitment
|
19 months
|
Number of Eligible Participants
Time Frame: 9 months
|
Number of eligible participants who agreed to participate
|
9 months
|
Acceptability - (Intervention Arm Only)
Time Frame: 9 months
|
Survey developed for study to assess how much caregivers liked different aspects of CONNECT; and a ~30min (approximately) qualitative interview to further explore acceptability (measures were not at all helpful, a little helpful, somewhat helpful or quite a bit helpful).
|
9 months
|
Acceptability - (Intervention Arm Only)
Time Frame: 9 months
|
Survey developed for study to assess how much caregivers liked different aspects of CONNECT; and a ~30min (approximately) qualitative interview to further explore acceptability (measures were strongly agree, agree and undecided).
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Supportive Care Utilization
Time Frame: 1 year
|
Adapted version of the 28-item Consumer-Based Cancer Care Value Index- Services and Resources instrument assessing use of services to meet multidimensional supportive needs.
Intervention caregivers will also self-report service use by completing an auto-generated REDCap survey to query about utilization of the specific resources that each caregiver expressed interest in accessing.
|
1 year
|
FAMCARE Questionnaire (Caregiver)
Time Frame: 1 year
|
A 20-item instrument with 4 subscales to assess family caregiver satisfaction with information giving, availability of care, physical patient care, and symptom control.
Participants will answer questions to indicate how satisfied they are with care family member has received.
(Subscales = (S) satisfied, (U) undecided, (D) dissatisfied or (VD) very dissatisfied
|
1 year
|
Caregiver Reaction Assessment
Time Frame: 1 year
|
Caregiver Reaction Assessment - 24-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health).
The CRA has been tested in cancer caregivers; demonstrated validity and reliability.
Each item is rated on a 1 to 4 scale. 1 (not at all) 2 (somewhat) 3 (quite a bit) 4 (completely)
|
1 year
|
PROMIS Emotional Distress-Anxiety-Short Form 8a
Time Frame: 1 year
|
An 8-item instrument that assesses fear, anxious misery, hyperarousal, and somatic symptoms related to arousal; widely used in oncology populations.
Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of anxiety.
|
1 year
|
PROMIS Emotional Distress- Depression-Short Form 8a
Time Frame: 1 year
|
An 8-item instrument that assesses sadness, guilt, self-criticism, worthlessness, loneliness, interpersonal alienation, as well as loss of interest, meaning, and purpose.
Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.
|
1 year
|
Caregiver Quality of Life Index-Cancer (CqoL-Canc)
Time Frame: 1 year
|
35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns).
Scoring scale is 0 = not at all to 4 = very much).
Maximum score of 140.
Higher scores indicate better quality of life.
|
1 year
|
Caregiver Risk Scale
Time Frame: 1 year
|
A 7-item measure to assess caregiver behaviors for managing self-care.
Questions are answered Yes or No and is a summation of the number of risks.
Score range of 0-7, the higher the number, the greater the risk.
|
1 year
|
Caregiving Self-Efficacy Scale
Time Frame: 1 year
|
21-item instrument assessing caregivers' perceived self-efficacy for coping with cancer (managing medical information, caring for care recipient, caring for oneself, managing difficult interactions/emotions). Uses a likert scale from 1 (not at all confident) to 9 (totally confident).
Higher scores indicate higher self-efficacy for coping with cancer.
|
1 year
|
Barriers to Supportive Care Use Survey
Time Frame: 1 year
|
A 16-item survey with an additional "other" category for a caregiver to report additional barriers not noted on the survey.
Response options range from never (0) to always (4).
Higher scores indicate a greater number of barriers.
|
1 year
|
Caregiver Adherence to Referral Survey
Time Frame: 1 year
|
Survey responses will be coded as "adhered" or "did not adhere" for agency- and caregiver- reported service utilization.
The score reporting is a dichotomous outcome of an adhered or not adhered.
|
1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Supportive Care Utilization
Time Frame: 1 year
|
Adapted version of the 28-item Consumer-Based Cancer Care Value Index- Services and Resources instrument assessing use of services to meet multidimensional supportive needs.
Intervention caregivers will also self-report service use by completing an auto-generated REDCap survey to query about utilization of the specific resources that each caregiver expressed interest in accessing.
|
1 year
|
FAMCARE Questionnaire (Caregiver)
Time Frame: 1 year
|
A 20-item instrument with 4 subscales to assess family caregiver satisfaction with information giving, availability of care, physical patient care, and symptom control.
Participants will answer questions to indicate how satisfied they are with care family member has received.
(Subscales = (S) satisfied, (U) undecided, (D) dissatisfied or (VD) very dissatisfied
|
1 year
|
Caregiver Reaction Assessment
Time Frame: 1 year
|
Caregiver Reaction Assessment - 24-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health).
The CRA has been tested in cancer caregivers; demonstrated validity and reliability.
Each item is rated on a 1 to 4 scale. 1 (not at all) 2 (somewhat) 3 (quite a bit) 4 (completely)
|
1 year
|
PROMIS Emotional Distress-Anxiety-Short Form 8a
Time Frame: 1 year
|
An 8-item instrument that assesses fear, anxious misery, hyperarousal, and somatic symptoms related to arousal; widely used in oncology populations.
Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of anxiety.
|
1 year
|
PROMIS Emotional Distress- Depression-Short Form 8a
Time Frame: 1 year
|
An 8-item instrument that assesses sadness, guilt, self-criticism, worthlessness, loneliness, interpersonal alienation, as well as loss of interest, meaning, and purpose.
Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.
|
1 year
|
Caregiver Quality of Life Index-Cancer (CqoL-Canc)
Time Frame: 1 year
|
35-item instrument assessing dimensions of caregiver quality of life (burden, disruptiveness, positive adaptation, financial concerns).
Scoring scale is 0 = not at all to 4 = very much).
Maximum score of 140.
Higher scores indicate better quality of life.
|
1 year
|
Caregiver Risk Scale
Time Frame: 1 year
|
A 7-item measure to assess caregiver behaviors for managing self-care.
Questions are answered Yes or No and is a summation of the number of risks.
Score range of 0-7, the higher the number, the greater the risk.
|
1 year
|
Caregiving Self-Efficacy Scale
Time Frame: 1 year
|
21-item instrument assessing caregivers' perceived self-efficacy for coping with cancer (managing medical information, caring for care recipient, caring for oneself, managing difficult interactions/emotions). Uses a likert scale from 1 (not at all confident) to 9 (totally confident).
Higher scores indicate higher self-efficacy for coping with cancer.
|
1 year
|
Barriers to Supportive Care Use Survey
Time Frame: 1 year
|
A 16-item survey with an additional "other" category for a caregiver to report additional barriers not noted on the survey.
Response options range from never (0) to always (4).
Higher scores indicate a greater number of barriers.
|
1 year
|
Caregiver Adherence to Referral Survey
Time Frame: 1 year
|
Survey responses will be coded as "adhered" or "did not adhere" for agency- and caregiver- reported service utilization.
The score reporting is a dichotomous outcome of an adhered or not adhered.
|
1 year
|
SF-12 Patient Measures - Physical/Emotional Well-being
Time Frame: 1 year
|
A 12-item instrument measuring physical and mental well-being, though our analyses will focus on physical well-being; widely used in oncology populations.
Physical and Mental Health Composite Scores (PCS & MCS) are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.
|
1 year
|
Unplanned Healthcare Utilization Survey
Time Frame: 1 year
|
Unplanned healthcare utilization survey will be calculated using a one item continuous score.
The survey will capture patient self-reported unplanned healthcare utilization (number of unplanned visits to the emergency room, urgent care, or healthcare provider) from time points of baseline to end of treatment.
|
1 year
|
FAMCARE Questionnaire (Patient)
Time Frame: 1 year
|
A 20-item instrument with 4 subscales to assess family caregiver satisfaction with information giving, availability of care, physical patient care, and symptom control.
Participants will answer questions to indicate how satisfied they are with care family member has received.
(Subscales = (S) satisfied, (U) undecided, (D) dissatisfied or (VD) very dissatisfied
|
1 year
|
PROMIS Emotional Distress-Anxiety-Short Form 8a for Patients
Time Frame: 1 year
|
An 8-item instrument that assesses fear, anxious misery, hyperarousal, and somatic symptoms related to arousal; widely used in oncology populations
|
1 year
|
PROMIS Emotional Distress- Depression-Short Form 8a for Patients
Time Frame: 1 year
|
An 8-item instrument that assesses sadness, guilt, self-criticism, worthlessness, loneliness, interpersonal alienation, as well as loss of interest, meaning, and purpose.Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.
Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of anxiety.
|
1 year
|
Patient - Quality of Life Functional Assessment of Cancer Therapy - Head and Neck (FACT-H&N)
Time Frame: 1 year
|
A 39-item instrument that measures physical, social, emotional, and functional well-being, as well as additional head and neck-related concerns.
Scoring scale is 0 = not at all to 4 = very much).
Maximum score of 156.
Higher scores indicate a better quality of life.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Chandylen Nightingale, PhD, MPH, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 16, 2020
Primary Completion (Actual)
May 31, 2022
Study Completion (Actual)
May 31, 2022
Study Registration Dates
First Submitted
March 4, 2019
First Submitted That Met QC Criteria
March 12, 2019
First Posted (Actual)
March 15, 2019
Study Record Updates
Last Update Posted (Actual)
April 27, 2023
Last Update Submitted That Met QC Criteria
April 4, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00056635
- 5KL2TR001421-04 (U.S. NIH Grant/Contract)
- WFBCCC 99519 (Other Identifier: Wake Forest Baptist Comprehensive Cancer Center)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Head and Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Mayo ClinicRecruitingCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
IRCCS Policlinico S. MatteoNestlé Health Science Spain; Akern SrlCompletedHead-neck CancerItaly
-
University of California, San FranciscoCompleted
-
Chinook Therapeutics, Inc. (formerly Aduro)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Head and Neck Cancer | Metastatic Head and Neck CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedHead And Neck CancerUnited States
-
Radboud University Medical CenterUnknown
-
Centre Oscar LambretUnknownEpidermoid Head and Neck CancerFrance
Clinical Trials on CONNECT
-
Columbia UniversityNational Institute of Mental Health (NIMH)Completed
-
Minnesota Department of HealthCompleted
-
University of South CarolinaNational Institute of Nursing Research (NINR)RecruitingConnect Through PLAY: A Staff-based Physical Activity Intervention for Middle School Youth (Connect)Physical Activity | Obesity PreventionUnited States
-
George Washington UniversityBill and Melinda Gates Foundation; Save the Children; Save the Children International...Active, not recruitingContraceptive UsageTanzania
-
RANDNational Institute of Mental Health (NIMH); University of Stellenbosch; Western...Enrolling by invitation
-
University of PittsburghNational Cancer Institute (NCI)CompletedAdvanced CancerUnited States
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH); Columbia University; Indiana University... and other collaboratorsEnrolling by invitation
-
Northwestern UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDropout | Attendance and Truancy | Student EngagementUnited States
-
Columbia UniversityNational Institute of Mental Health (NIMH); Chestnut Health Systems; George Mason...SuspendedSuicideUnited States
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Substance Use | Substance Use Disorders | Substance Abuse | Substance Dependence | Substance Related Problem